Fluoxetine for stroke recovery improvement – the doubleblind, randomised placebo-controlled FOCUS-Poland trial | Zendy

Jan Bembenek | Zendy; Maciej Niewada | Zendy; Bożena Kłysz | Zendy; Anna Mazur | Zendy; Katarzyna Kurczych | Zendy; Marcin Głuszkiewicz | Zendy; Anna Członkowska | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fluoxetine for stroke recovery improvement – the doubleblind, randomised placebo-controlled FOCUS-Poland trial

Author(s) -

Jan Bembenek,

Maciej Niewada,

Bożena Kłysz,

Anna Mazur,

Katarzyna Kurczych,

Marcin Głuszkiewicz,

Anna Członkowska

Publication year - 2020

Publication title -

neurologia i neurochirurgia polska

Language(s) - English

Resource type - Journals

eISSN - 1897-4260

pISSN - 0028-3843

DOI - 10.5603/pjnns.a2020.0099

Subject(s) - medicine , fluoxetine , placebo , stroke (engine) , modified rankin scale , clinical trial , randomized controlled trial , odds ratio , adverse effect , confidence interval , cohort , physical therapy , ischemic stroke , mechanical engineering , alternative medicine , receptor , ischemia , pathology , serotonin , engineering

The Fluoxetine Or Control Under Supervision (FOCUS)-Poland trial tested in a Polish cohort the hypothesis that fluoxetine improves recovery after stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research